Biotechnology
Technology
Health

China Biologic Products

$87.23
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.19 (-1.35%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell CBPO and other stocks, options, ETFs, and crypto commission-free!

About

China Biologic Products Holdings, Inc. engages in the research, development, manufacture and sale of human plasma-based biopharmaceutical products or plasma products. Its products include plasma and other products. Read More The company was founded in 2002 and is headquartered in Beijing, China.

Employees
2,187
Headquarters
Beijing, Beijing
Founded
2002
Market Cap
3.43B
Price-Earnings Ratio
23.76
Dividend Yield
0.00
Average Volume
276.46K
High Today
$88.64
Low Today
$86.76
Open Price
$88.19
Volume
54.44K
52 Week High
$107.44
52 Week Low
$60.08

Collections

Biotechnology
Technology
Health
Biopharmaceutical
Pharmaceutical
China
Asia

News

Yahoo FinanceMar 20

New Strong Sell Stocks for March 20th

Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today: Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: China Biologic Products Holdings, Inc. CBPO is a manufacturer of human plasma-based biopharmaceutical products. The Zacks Consensus Estimate for its current year earnings has been revised 6% downward over the last 30 days. Donegal Group Inc. DGICA is an insurance holding company. The Zacks Consensus Estimate for its current year earnings has been revised 31.3% downw...

18
Yahoo FinanceMar 19

See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

China Biologic Products Holdings Inc NASDAQ/NGS:CBPO View full report here! Summary Bearish sentiment is low Bearish sentiment Short interest | Positive Short interest is low for CBPO with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows o...

3
MarketBeatMar 14

Stock Price, News, & Analysis for China Biologic Products

China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-den...

0

Earnings

-$0.24
$0.30
$0.85
$1.39
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
β€”
Actual
Expected May 3, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.